KLEMA CATHY

CIK 00011811574 companiesWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001181157

Recent Transactions

47 trades

Award
OptimizeRx Corp$OPRX
Common Stock
2026-06-09+34,517→ 56,137 total
Award
OptimizeRx Corp$OPRX
Common Stock
2025-06-11+9,868→ 21,620 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Common Stock
2025-02-02+5,109→ 11,752 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Restricted Stock Units
2025-02-02−5,109→ 0 total
Award
OptimizeRx Corp$OPRX
Common Stock
2024-06-07+6,643→ 6,643 total
Award
OptimizeRx Corp$OPRX
Restricted Stock Units
2024-02-02+5,109→ 5,109 total
Tax Payment
Allergan plc
Ordinary Shares, par value $0.0001
2019-04-30$147.00/sh−953→ 25,081 total
Other
Allergan plc
Ordinary Shares, par value $0.0001
2019-03-11+410→ 26,034 total
Award
Allergan plc
Ordinary Shares, par value $0.0001
2018-05-02$151.07/sh+1,985→ 25,624 total
Award
Allergan plc
Ordinary Shares, par value $0.0001
2017-05-04$245.25/sh+1,223→ 23,639 total
Award
Allergan plc
Ordinary Shares, par value $0.0001
2016-08-08$248.31/sh+201→ 22,416 total
Award
Allergan plc
Ordinary Shares, par value $0.0001
2016-05-05$210.34/sh+1,188→ 22,215 total
Award
Allergan plc
Ordinary Shares, par value $0.0001
2015-06-05$302.30/sh+826→ 21,027 total
Award
Allergan plc
Ordinary Shares, par value $0.0001
2015-06-05$302.30/sh+826→ 21,027 total
Tax Payment
Allergan plc
Ordinary Shares, par value $0.0001
2015-06-04$303.38/sh−549→ 20,201 total
Tax Payment
Allergan plc
Ordinary Shares, par value $0.0001
2015-06-04$303.38/sh−549→ 20,201 total
Award
Allergan plc
Ordinary Shares
2013-10-01+19,608→ 19,608 total
Disposition to Issuer
Allergan Finance LLC
Common Stock, par value $0.0033
2013-10-01−19,608→ 0 total
Sale
Allergan Finance LLC
Common Stock, par value $0.0033
2013-08-12$133.03/sh−1,667→ 19,608 total
Gift
Allergan Finance LLC
Common Stock, par value $0.0033
2013-08-09−3,334→ 21,275 total
Gift
Allergan Finance LLC
Common Stock, par value $0.0033
2013-08-06−5,000→ 24,609 total
Award
Allergan Finance LLC
Common Stock, par value $0.0033
2013-05-10+1,877→ 29,609 total
Exercise/Conversion
Allergan Finance LLC
Non-Qualified Options to Purchase Common Stock
2012-07-31−5,000→ 0 total
Exercise/Conversion
Allergan Finance LLC
Common Stock, par value $0.0033
2012-07-31$29.03/sh+5,000→ 49,432 total
Sale
Allergan Finance LLC
Common Stock, par value $0.0033
2012-07-31$78.38/sh−5,000→ 32,732 total
Exercise/Conversion
Allergan Finance LLC
Common Stock, par value $0.0033
2012-07-31$30.12/sh+5,000→ 44,432 total
Sale
Allergan Finance LLC
Common Stock, par value $0.0033
2012-07-31$78.38/sh−11,700→ 37,732 total
Sale
Allergan Finance LLC
Common Stock, par value $0.0033
2012-07-31$78.38/sh−5,000→ 27,732 total
Exercise/Conversion
Allergan Finance LLC
Non-Qualified Options to Purchase Common Stock
2012-07-31−5,000→ 0 total
Exercise/Conversion
Allergan Finance LLC
Common Stock, par value $0.0033
2012-07-31$44.14/sh+11,700→ 39,432 total
Exercise/Conversion
Allergan Finance LLC
Non-Qualified Options to Purchase Common Stock
2012-07-31−11,700→ 0 total
Award
Allergan Finance LLC
Common Stock, par value $0.0033
2012-05-11+2,887→ 27,732 total
Award
Allergan Finance LLC
Common Stock, par value $0.0033
2011-05-13+3,177→ 24,845 total
Award
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2011-01-03+2,355→ 16,199 total
Award
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Stock Options (to buy)
2010-07-30+9,090→ 9,090 total
Award
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Stock Options (to buy)
2010-05-20+10,140→ 10,140 total
Award
Allergan Finance LLC
Common Stock, par value $0.0033
2010-05-07+5,000→ 21,668 total
Award
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2010-01-04+2,799→ 13,844 total
Award
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Stock Options (to buy)
2009-05-20+13,577→ 13,577 total
Award
Allergan Finance LLC
Common Stock, par value $0.0033
2009-05-08+5,000→ 16,668 total
Award
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2009-01-02+2,242→ 11,045 total
Award
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2008-01-02+1,588→ 8,803 total
Award
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2006-01-03+1,032→ 2,612 total
Award
Allergan Finance LLC
Non-Qualified Options to Purchase Common Stock
2005-06-29+5,000→ 5,000 total
Award
Allergan Finance LLC
Common Stock - restricted stock
2005-06-29+1,667→ 1,667 total
Award
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Stock Options (to buy)
2005-05-18+2,729→ 36,729 total
Award
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2005-01-03+1,580→ 1,580 total

KLEMA CATHY

Recent Transactions

Companies

Recent Filings

Address